Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Markus Puhlmann is Chief Medical Officer at Perspective Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Nov 13, 2026, each linked to the official Form 4.
Chief Medical Officer
Disclosures on record
2
Companies involved
1
As of the latest filing on , Markus Puhlmann reported holding 178,542 shares of Perspective Therapeutics (CATX), worth about $168K at the last close of $1 (Nov 13, 2026). In the last 12 months, Markus Puhlmann bought $35K in 2 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Perspective Therapeutics CATX | 178,542 | 179K direct | $1 | $168K | Nov 12, 2026 |
Is this Markus Puhlmann’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Perspective TherapeuticsCATX
2 disclosures · Nov 2026 · 2 bought
Nov 12, 2026Bought~$30Kdisclosed Nov 13
DetailsOfficial recordNov 11, 2026Bought~$5Kdisclosed Nov 13
DetailsOfficial recordMarkus Puhlmann bought shares on the open market in 2023, 2024 and 2026.
Markus Puhlmann reported 6 open-market purchases and 0 sales since 2023; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $35K2×2 trades | — |
| 2024 | $140K1×1 trade | — |
| 2023 | $188K3×3 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 12, 2026, Markus Puhlmann reported holding 178,542 shares of Perspective Therapeutics (CATX). At the last close of $1 on Nov 13, 2026, that is about $168K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Markus Puhlmann reported 2 open-market purchases worth $35K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Markus Puhlmann bought shares on the open market in 2023, 2024 and 2026.
In SEC filings since 2023: the latest open-market purchase is from 2026; no open-market sale is on record.
Perspective Therapeutics (CATX), from 2023 to 2026: 6 purchases and 0 sales.
Markus Puhlmann reported 6 open-market purchases and 0 sales here, 2023 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
